Pratima P. Mogle
Swami Ramanand Teerth Marathwada University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pratima P. Mogle.
Medicinal Chemistry Research | 2017
Shrikant V. Hese; Rohan J. Meshram; Rahul D. Kamble; Pratima P. Mogle; Kapil K. Patil; Sonali S. Kamble; Rajesh N. Gacche; Bhaskar S. Dawane
Diabetes is embracing the human population in logarithmic fashion both in developed as well as developing countries. Aldose reductase is one of the important enzymes of polyol pathway of sugar metabolism in humans. Aldose reductase inhibition has been identified as one of the important target for developing novel antidiabetic agents. In this report, we present an effective synthesis of 7-(substituted phenyl) chromeno-pyrano [2,3-d]pyrimidine-6,8,10-(7H,9H,11H)-trione derivatives and demonstrate their aldose reductase inhibition potential in order to identify novel schemes for finding putative aldose reductase inhibitors. The antioxidant activity of all the synthesized compounds with negligible toxicity demonstrates the biological efficacy of the synthesized compounds. The in silico molecular docking and structural analysis of docked poses conducted in the current investigation sheds light on the structural rationale of the observed aldose reductase inhibition by all the newly synthesized compounds.
MedChemComm | 2016
Pratima P. Mogle; Rohan J. Meshram; Shrikant V. Hese; Rahul D. Kamble; Sonali S. Kamble; Rajesh N. Gacche; Bhaskar S. Dawane
Various substituted 2-(2-(5-(3/4-substituted phenyl)-4-hydroxy-3′-(3/4-substituted phenyl)-1′-phenyl-1H,1′H-[3,4′-bipyrazol]-1-yl)thiazol-4(5H)ylidene) hydrazinecarbothioamide derivatives have been synthesized in good yields by an efficient method. The synthesized compounds (6a–r) were evaluated for their in vitro antitubercular activity against the Mycobacterium tuberculosis (MTCC 300) strain. Compounds 6o (MIC-3.90 μg mL−1), 6p (MIC-3.90 μg mL−1), and 6q (MIC-7.81 μg mL−1), exhibited significant activity against Mycobacterium tuberculosis. The molecular docking studies revealed an interesting binding profile with very high receptor affinity.
Research on Chemical Intermediates | 2015
Milind V. Gaikwad; Rahul D. Kamble; Shrikant V. Hese; Ashok P. Acharya; Pratima P. Mogle; Shuddhodan N. Kadam; Bhaskar S. Dawane
We report bleaching earth clay pH 12.5/PEG-400 as an efficient catalytic system for preparation of α,β-unsaturated ketones (chalcones). The method presents one or more advantages over existing methodologies such as shorter reaction time, excellent yield, and low cost. All synthesized products were characterized by spectroscopic and analytical measurements.
Phosphorus Sulfur and Silicon and The Related Elements | 2016
Madhav J. Hebade; Rahul D. Kamble; Shrikant V. Hese; Pratima P. Mogle; Ajay N. Ambhore; Shuddhodan N. Kadam; Bhaskar S. Dawane
GRAPHICAL ABSTRACT ABSTRACT An efficient, green, rapid multitasking protocol for the selective C-5 substitution of 2-aminothiazole using iodic acid and aqueous PEG-400 was developed. The method found suitable for C-5 substitution i.e. iodination and thiocyanation of 2-amino thiazole using iodine and ammonium thiocyanate respectively. Iodic acid was found to be a good oxidant and aqueous PEG-400 as green reaction solvent.
Research on Chemical Intermediates | 2015
Pratima P. Mogle; Rahul D. Kamble; Shrikant V. Hese; Bhaskar S. Dawane
A green, efficient, and simple method for synthesis of 5,6,7,8-tetrahydroquinoline-3-carbonitrile derivatives via one-pot three-component condensation of 2,6-bis(substituted benzylidene)cyclohexanone, arylamines/substituted 2-aminothiazoles, and malononitrile in the presence of bleaching earth clay pH 12.5 (basic catalyst) as a recyclable and green catalyst in PEG-400 is described. Catalyst recyclability, good to excellent product yield, shorter reaction time, and avoidance of hazardous reagents are the main advantages of this methodology.
Der Pharma Chemica | 2017
Ajay N. Ambhore; Rahul D. Kamble; Pratima P. Mogle; Shrikant V. Hese; Shuddhodan N. Kadam; Madhav J. Hebade; Sonali S. Kamble; Rajesh N. Gacche; Bhaskar S. Dawane
Der Pharmacia Lettre | 2015
Shital S. Kadam; Pratima P. Mogle; Ajay N. Ambhore; Rahul D. Kamble; Shrikant V. Hese; Siddhodhan N. Kadam; Bhaskar S. Dawane
Der Pharma Chemica | 2015
Shrikant V. Hese; Rahul D. Kamble; Pratima P. Mogle; Shital S. Kadam; Madhav J. Hebade; Ajay N. Ambhore; Bhaskar S. Dawane
Der Pharma Chemica | 2015
Ajay N. Ambhore; Vishwash D. Surywanshi; Rahul D. Kamble; Shrikant V. Hese; Pratima P. Mogle; Shital S. Kadam; Bhaskar S. Dawane
Archive | 2014
Pravin N. Muli; Santosh S. Chobe; Rahul D. Kamble; Shrikant V. Hese; Pratima P. Mogle; Bhaskar S. Dawane